首页 / 院系成果 / 成果详情页

Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells  期刊论文  

  • 编号:
    82d4e7f9-6eb0-43ef-ad2c-85b664dc920b
  • 作者:
    Wang, Yingge#[1,2,3,4,5]Gao, Shan[6];Wang, Weiguang[7];Liang, Jingyan*[2,3,4,8]
  • 语种:
    英文
  • 期刊:
    MOLECULAR MEDICINE REPORTS ISSN:1791-2997 2016 年 14 卷 6 期 (5732 - 5738) ; DEC
  • 收录:
  • 关键词:
  • 摘要:

    Temozolomide (TMZ) is an alkylating agent used for the treatment of aggressive forms of brain tumor based on its antitumor actions. However, the exact effect on cancer and the underlying anticancer molecular mechanism of TMZ remain to be elucidated. In the present study, the effects of TMZ on the growth and motility of glioma C6 cells were investigated. MTT and Transwell assays were used to detect cellular growth and motility. The results showed that TMZ inhibited the proliferation, migration and invasion of the glioma C6 cells in vitro, western blot analysis determined that the phosphorylation of extracellular signal-regulated protein kinase (ERK)1/2 was decreased in the TMZ-treated cells, compared with the untreated control cells. The ERK1/2 specific inhibitor, U0126, augmented the inhibitory effects of TMZ on the proliferation, migration and invasion of the glioma C6 cells, and the mitogen-activated protein kinase kinase/ERK pathway activator, curcumin, attenuated the inhibitory effects of TMZ on the proliferation and motility of the glioma C6 cells. Additionally, the western blotting in the present study demonstrated that TMZ and U0126 decreased the expression of vascular endothelial growth factor-C (VEGF-C), and the expression level was restored by curcumin, suggesting that VEGF-C may be the downstream effector of ERK1/2. Furthermore, the overexpression of VEGF-C enhanced the growth, migration and invasion of the TMZ-treated cells. These results suggested that TMZ suppressed glioma C6 cell development, at least in part, and downregulated the expression of VEGF-C by inhibiting the ERK signaling pathway. The results of the present study provides the foundation for a combinational therapeutic strategy to improve the efficacy of TMZ.

  • 推荐引用方式
    GB/T 7714:
    Wang Yingge,Gao Shan,Wang Weiguang, et al. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells [J].MOLECULAR MEDICINE REPORTS,2016,14(6):5732-5738.
  • APA:
    Wang Yingge,Gao Shan,Wang Weiguang,Liang Jingyan.(2016).Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells .MOLECULAR MEDICINE REPORTS,14(6):5732-5738.
  • MLA:
    Wang Yingge, et al. "Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells" .MOLECULAR MEDICINE REPORTS 14,6(2016):5732-5738.
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:6 下载次数:0
浏览次数:6
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部